Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice.

@article{Zou2012QiliqiangxinIT,
  title={Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice.},
  author={Yun-zeng Zou and Li Lin and Yong Ye and Jianming Wei and Ning Zhou and Yanyan Liang and Hui Gong and Lei Erbao Li and Jian Wu and Yunbo Li and Zhenhua Jia and Yiling Wu and Jingmin Zhou and Junbo Ge},
  journal={Journal of cardiovascular pharmacology},
  year={2012},
  volume={59 3},
  pages={268-80}
}
Qiliqiangxin (QL), a traditional Chinese medicine, has been used in the treatment of chronic heart failure. However, whether QL can benefit cardiac remodeling in the hypertensive state is unknown. We here examined the effects of QL on the development of cardiac hypertrophy through comparing those of losartan in C57BL/6 mice underlying transverse aorta… CONTINUE READING